Findings in Pancreatic Cancer Reported from Van Andel Institute (Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, Stra)

MLA

“Findings in Pancreatic Cancer Reported from Van Andel Institute (Detection of Chemotherapy-Resistant Pancreatic Cancer Using a Glycan Biomarker, Stra).” Hematology Week, 22 Feb. 2021, p. 2768. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.652554519&authtype=sso&custid=ns315887.

APA

Findings in Pancreatic Cancer Reported from Van Andel Institute (Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, Stra). (2021, February 22). Hematology Week, 2768.

Chicago

Hematology Week. 2021. “Findings in Pancreatic Cancer Reported from Van Andel Institute (Detection of Chemotherapy-Resistant Pancreatic Cancer Using a Glycan Biomarker, Stra),” February 22. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.652554519&authtype=sso&custid=ns315887.